Transforming Growth Factor-&bgr;: A Molecular Target for the Future Therapy of Glioblastoma

E-ISSN： 1873-4286|12|3|341-349

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.3, 2006-01, pp. : 341-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Involvement of the Transforming Growth Factor &bgr; in the Pathogenesis of Hereditary Hemorrhagic Telangiectasia

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1195-1200

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Products and Transforming Growth Factor-beta (TGF-&bgr;) Signaling in Cancer Development and Progression

Current Cancer Drug Targets, Vol. 13, Iss. 5, 2013-06 ,pp. : 500-505

Bentham Science Publishers

Access to resources Recommend Favorite

Transforming Growth Factor-&bgr;1 Induces Endothelin-1 in a Bovine Pulmonary Artery Endothelial Cell Line and Rat Lungs via cAMP

By Lee S.D. Lee D.S. Chun Y.G. Paik S.H. Kim W.S. Kim D.S. Kim W.D. Tuder R.M. Voelkel N.F.

Pulmonary Pharmacology & Therapeutics, Vol. 13, Iss. 6, 2000-12 ,pp. : 257-265

Academic Press

Access to resources Recommend Favorite

Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions

By Patel Mital Vogelbaum Michael A Barnett Gene H Jalali Rakesh Ahluwalia Manmeet S

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1247-1266

Informa Healthcare

Access to resources Recommend Favorite

Atypical PKCι as Target for Glioblastoma Therapy

Current Cancer Drug Targets, Vol. 15, Iss. 2, 2015-02 ,pp. : 136-144

Bentham Science Publishers

Access to resources Recommend Favorite